Skip to main content
Caplight Logo









OncoOne

OncoOne

Private
ViennaHealthcare & Life Scienceshttps://www.oncoone.com/

Last Round

Series B

Apr 1, 2022

Total Funding Raised

$14.26M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OncoOne is a biotechnology company that develops precision medicines for cancer and chronic inflammatory diseases using its proprietary antibody-based targeting platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

radioimmunotherapybispecific antibodiesprecision medicinedrug discoverymonoclonal antibodybiotechsolid tumor treatmentpretargeted therapyantibody engineeringradioligand therapytargeted cancer therapyoxMIFinflammatory disease treatmentbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoOne Comparables

Compare OncoOne with similar companies based on industry and business-model similarity.

OncoOne comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PreTT ApS
78%
Y-mAbs Therapeutics
76%
Akiram Therapeutics
76%

OncoOne Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 1, 2022
Series AMar 18, 2020

Key People

Founding team and executive leadership

Alexander Schinagl

Co-Founder and Chief Technology Officer

Founding Team

OncoOne Investors

Notable investors and investment history

OncoOne investors
InvestorRounds
Austria WirtschaftsserviceSeries A
FFG Austrian Research Promotion AgencySeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 349% MoM, from 243 to 1.1K.

  • May 14, 2026

    Monthly visitors grew 68% MoM.

OncoOne Filings

Explore SEC and related filing metadata, where available.

OncoOne filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OncoOne's valuation, stock price, and market status.

Is OncoOne a public or private company?

OncoOne is a private company.

What is the current stock price of OncoOne?

OncoOne is a private company with no public stock price. No recent secondary market data is available.

How much is OncoOne worth (valuation)?

Valuation information for OncoOne is not publicly available.

Can I buy OncoOne stock?

OncoOne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OncoOne's last funding round?

OncoOne's most recent funding round was Series B on April 1, 2022.

Who are the main investors in OncoOne?

Key investors in OncoOne include Austria Wirtschaftsservice, FFG Austrian Research Promotion Agency.

Will OncoOne IPO soon?

No public IPO plans have been announced for OncoOne.

How can I track OncoOne secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoOne's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVienna
Employee Range9
Year Founded2018
Last FundingApr 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?